Platelet disorders 2

Details

Title

Platelet disorders 2

Type

Stage Two

Module code

HLS177

Requirement

Compulsory

Module objective

By the end of the training period trainees will, in respect of platelet disorders, be able to:

• analyse, synthesise, evaluate and apply knowledge
• perform, adapt and master a range of technical and clinical skills and procedures
• demonstrate the attitudes and behaviours necessary for professional practice as a consultant clinical scientist dealing with the complexities, uncertainties and tensions of professional practice at this level.

Knowledge and understanding

By the end of the training period the trainee will be able to demonstrate the ability to analyse, evaluate and synthesise relevant knowledge and its application to their professional practice in relation to:

• quantitative platelet disorders: platelet production and metabolic pathways, thrombocytopenia and mechanisms (sequestration, decreased production, increased destruction), immune thrombocytopenia, pregnancy-associated thrombocytopenia, drug-induced thrombocytopenia, heparin-induced thrombocytopenia, disseminated intravascular coagulation, TTP/HUS, neonatal thrombocytopenia, thrombocytosis
• qualitative platelet disorders: inherited disorders, Bernard Soulier syndrome, Glanzmann’s thrombasthenia, platelet receptor abnormalities, platelet granule abnormalities, membrane phospholipid abnormalities
• acquired platelet defects: uremia, myeloproliferative disorders, cardiopulmonary bypass, drug-induced, liver disease
• clinical aspects: therapeutic principles and measures.

Technical and clinical skills

By the end of the training period the trainee will be able to demonstrate a critical understanding of current relevant research, theory and knowledge and its application to the performance, adaptation and mastery of the following technical procedures and laboratory skills:

• be competent in the laboratory investigation, diagnosis and monitoring of patients with quantitative platelet disorders
• understand the clinical management of platelet disorders.